We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Presents Latest Solutions for Women's Health and Infectious Disease Diagnosis

By LabMedica International staff writers
Posted on 05 Feb 2025

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is participating in Medlab Middle East 2025 where it is featuring advanced solutions for vaginal microbiota testing and self-sampling for women's health.

Bioperfectus is demonstrating the SS-AMS3000 automated reproductive tract microbiota microscopic image analysis system at the event. This system consists of an optical imaging system (including the light source, automatic platform, objective lens, and lens barrel), an image acquisition system (camera), and software (including control and analysis functions), which need to be used with a computer. The system’s operating principle is to magnify and capture images of reproductive tract samples on slides for user observation. It also enables the analysis of cells and microorganisms in microscopic images. Alongside, Bioperfectus is highlighting the SDA-90 automated stainer which is used for staining treatment of blood and other body fluids before sample analysis. It integrates new technologies such as machinery, electricity, and computer software to achieve fully automatic staining of samples. The SDA-90 automated stainer is used together with the stain reagents produced by BioPerfectus for staining of blood and other body fluids before sample analysis. It can be connected with the BioPerfectus Biological Automatic Microscope to realize fully automatic assembly line detection of vaginal microecological morphology.

BioPerfectus is also showcasing its comprehensive solution for cervical cancer screening, aiming to accelerate the global elimination of cervical cancer. This solution has tested over 10 million women, covering over 60 countries and regions worldwide. It can be customized to meet various application scenarios. The Quantitative HPV Genotyping Detection, designed for single-visit screening and optimization of HPV testing triage, brings higher cost efficiency. The 16+2 high-risk testing option caters to large-scale population screening. Integration with internet hospitals and self-sampling testing facilitates at-home testing, enhancing convenience and expanding the coverage of screening.


New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Portable Electronic Pipette
Mini 96
Pipette
Accumax Smart Series
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.